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Because biochemical "feminization" of the liver In males Is observed with he-
patiC regeneration and because the hepatic regenerative response In females 
is greater than that In males. the possibility that antlandrogens might potentiate 
liver regeneration was investigated. Before 70% hepatectomy. adult male Wlstar 
rats were treated with cimetldlne. an antlandrogenlc H2 antagonist. at doses 
up to10 times greater than those used Clinically. Control animals received either 
the saline vehicle or ranltldlne. an H2 antagonist without antlandrogenlc prop-
erties. Treatment with clmetidlne reduced the hepatic cytosollc androgen re-
ceptor content compared with ranltldine treatment. Hepatectomy caused a 
further reduction in androgen receptor activity In all groups. Hepatic cytosollc 
estrogen receptor activity was comparable In all groups throughout the study. 
Moreover. the rate of liver growth and the levels of ornithine decarboxylase and 
thymidine kinase activity Induced as part of the regenerative response were 
similar in all groups. Thus. clmetldlne. despite its ability to bind to androgen 
receptors. and ranltidlne. an H2 receptor antagonist without anllandrogen ac-
tion. do not modulate the hepatic regenerative response to a 70% partial hep-
atectomy. (J LAB CUN MEo 1988;112:232-9) 
Despite the fact that the liver is not generally considered a classical target for sex honnones, 
it has been shown to have a number of sexually 
dimorphic characteristics. I.3 Recent data have demon-
strated that during the regenerative response that fol-
lows partial hepatectomy, the liver in the male rat is 
"demasculinized" in that it loses many of its male-
specific attributes.4 Neither the regUlation of this de-
masculinization process nor the biologic significance of 
hepatic demasculinization associated with hepatic re-
generation is understood. Moreover, it is well known 
that the regenerative response of female animals is 
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greater than that of male animals to a wide variety of 
hepatotoxic stimuli. An extension of these data is that 
agents with antiandrogenic properties might have the 
potential to enhance the rate of hepatic regeneration 
after liver injury by augmenting the demasculinization 
ofthe liver. This hypothesis has been evaluated by using 
a standard rat model of hepatic regeneration after two-
thirds hepatectomy. 5Cimetidine was chosen as the drug 
for these experiments because of its widespread clinical 
use. In addition to its antagonism of H2 receptor-
mediated functions, it also has been shown to have 
antiandrogenic properties, including the ability to bind 
to androgen receptors. 6·8 
METHODS 
Animals and supplies. Adult male inbred Wistar rats (200 
to 350 gm) were used in these studies. They were purchased 
from Harlan Sprague-Dawley, Indianapolis, Ind. Cimetidine 
(SK&F Co., Philadelphia, Pa.) and ranitidine (Glaxo Inc., 
Research Triangle Park, N.C.) were obtained from the 
pharmacy of the Presbyterian University Hospital (Pitts-
burgh, Pa.). Dupont NEN Medical Products, Boston, Mass., 
was the source for the carbon 14-labeled ornithine (57.6 
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mCi/mmol), tritiated estradiol (99 Cilmmol), tritiated Rl181 
(87 Ci/mmol), and unlabeled RI881 used in these experi-
ments. Tritiated thymidine and ACS scintillation fluid were 
purchased from Amersham Corp., Arlington Heights, m. Ab-
solute ethanol and DEAE-cellulose paper were purchased 
from U.S. Industrial Chemicals Co., Tuscola, Ill., and Bio-
Rad Laboratories, Richmond, Calif., respectively. Unlabeled 
ornithine, pyridoxal phosphate, Tris base, diethylstilbestrol, 
adenosine triphosphate, sodium molybdate, nicotinamide ad-
enine dinucleotide, and bovine serum albumin were purchased 
from Sigma Chemical Co., St. Louis. All other chemicals 
were purchased from Fisher Chemical Co., Pittsburgh, Pa. 
Drug dosages. The cimetidine and ranitidine dosages 
used were based on the dosages used clinically in humans for 
the active treatment of duodenal ulcer disease. The dosage 
identified as "1 x" in the text and figures corresponds to 17 
mg/kg for cimetidine and 4.3 mg/kg for ranitidine, respec-
tively. The dosages identified as "5 x" and "10 x" represent 
five times and 10 times the dosages used at "1 x" for each 
of the two drugs. The drugs were diluted as necessary with 
saline solution, such that both experimental and control an-
imals received 0.5 ml saline solution per injection. 
Animal treatment and tissue preparation. Male Wistar 
rats were assigned randomly to the various treatment groups. 
Animals in the experimental groups were given the appro-
priate dose of either cimetidine or ranitidine dissolved in 0.5 
ml saline solution administered intraperitoneally beginning 
72 hours before partial hepatectomy and every 24 hours there-
after until the time the animals were killed. Animals used as 
placebo controls received 0.5 ml saline solution, which was 
administered intraperitoneally by using the same dosing 
schedule. A two-thirds partial hepatectomy was performed, 
as described by Higgins and Anderson,' between 9 and 12 
AM with the animals under ether anesthesia. The liver tissue 
removed at the time of hepatectomy was used to determine 
the baseline values for all of the parameters assessed. 
At 6, 12, 24, and 48 hours after hepatectomy, animals 
from the control group and both drug treatment groups were 
anesthetized with ether and weighed. The liver remnant was 
removed, weighed, and homogenized in 4 vol ice-cold buffer 
consisting of 0.25 mollL sucrose, 1.5 mmollL EDTA, 10 
mmol/L mercaptoethanol, and 10 mmollL Tris HCl (pH 7.4) 
by using a Polytron homogenizer. Cytosol was prepared by 
centrifugation at 103,000 g for 1 hour at 40 C. All cytosolic 
enzyme assays were performed immediately after preparation 
of the cytosol. 
Ornithine decarboxylase assay. Ornithine decarbox-
ylase activity was determined in vitro by measuring the release 
of 14COZ from labeled ornithine. 9 In this assay, 0.4 ml cytosol 
was preincubated for 5 minutes at 37° C with a mixture con-
taining 0.2 mmollL pyridoxal phosphate, 5 mmollL di-
thiothreitol, I.S mmollL L-ornithine in 10 mmollL Tris HCI 
(pH 8.0). At the end of this period, 1 j.1Ci L- 14C-DL-ornithine 
was added to the mixture and 2S0 j.11 ethanolamine-ethylene 
glycol (2: 1) was added to a center well to act as a COz trap. 
The assay flask was sealed and incubated at 37° C for 1 hour. 
The reaction was terminated by the injection of 0.1 ml 100% 
(wtlvol) trichloroacetic acid solution into the reaction mixture 
through the top. After the reaction flask had been maintained 
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at 370 C for an additional hour, the COz trapping solution 
was removed and placed directly into a glass scintillation vial 
containing 10 ml ACS scintillation fluid. Radioactivity was 
measured in a Packard Tri-Carb 460 CD liquid scintillation 
system (Packard Instrument Co., Downers Grove, 111.). 
Thymidine kinase assay. Thymidine kinase activity was 
determined by measuring the in vitro conversion ofthymidine 
to thymidine phosphate. \0 Cytosol (0.1 ml) was mixed with 
8S0 j.1l incubation buffer consisting of S mmol / L adenosine 
triphosphate, 3.6 mmol/L MgCl2 in SO mmollL Tris HCI 
(pH 8.0), and 50 j.11 of 1 j.1mollL tritiated thymidine. The 
reaction was maintained at 370 C for 10 minutes and termi-
nated by immersion in boiling water for 2 minutes. After 
cooling in an ice bath, the mixture was centrifuged for S 
minutes at 4° C at ISoo g to remove denatured protein. An 
aliquot (0.1 ml) of the supernatant was spotted on a 3.8 x 3.8 
cm piece of DEAE-cellulose paper. The paper was washed 
twice with 1 mmollL ammonium formate for S minutes fol-
lowed by distilled water for 3 minutes. Next, the paper was 
placed in a glass scintillation vial and the radioactivity bound 
to the paper was eluted into solution by the addition of 1 ml 
of 0.1 moUL HCI-0.2 mollL KCI. After IS minutes, 10 ml 
ACS scintillation fluid was added, and the tritium present in 
the vial was determined. 
Cytosollc sex sterOid receptor assays. The activity of 
the cytosoIic estrogen receptors was determined by measuring 
the specific binding at a saturating concentration of tritiated 
estradiol. II The cytosol, prepard as noted above, was diluted 
1: 1 with buffer consisting of 40 mmollL sodium molybdate, 
I.S mmol!L EDTA, and 10 mmol/L Tris HCI (pH 7.4) to 
stabilize the receptors. To measure total binding of the ligand, 
200 j.11 of this diluted cytosol was mixed with 2S j.11 of 30 
nmol/L radioactive ligand and 2S 111 ethanol. Nonspecific 
binding was measured in parallel assays in which the ethanol 
was replaced with 25 ILl of 3 I1mollL unlabeled diethylstil-
bestrol dissolved in ethanol. After 2 hours at 4° C, the in-
cubation was terminated by the addition of 0.4 ml 1 % dextran-
coated charcoal to each tube to remove unbound ligand. This 
suspension was centrifuged for S minutes at ISoo g at 40 C, 
and the supernatant was carefully transferred to a scintillation 
vial containing 8 ml ACS scintillation fluid. The radioactivity 
in the vial was measured. 
The cytosolic androgen receptor assay used was similar in 
design to that described for the estrogen receptor assay.' Tri-
tiated RI88I, a synthetic androgen, was used as the labeled 
ligand, and unlabeled RI881 was used in the nonspecific 
binding assays. Triamcinolone acetonide (5 I1mollL) was 
included in all androgen assays to block binding of RI881 to 
glucocorticoid receptors. The only other difference between 
the two methods is that in the androgen receptor assay the 
cytosol was incubated at 0° C overnight rather than for 2 
hours as in the estrogen receptor assay. 
Miscellaneous methods and procedures. Protein con-
centrations were determined by the method of Lowry et al. 12 
with bovine serum albumin being used as the standard. Sta-
tistical analysis of the data was performed with one-way anal-
ysis of variance followed by Scheffe's test through the Abstat 
program on an IBM PC-XT computer (IBM Corp., Valhalla, 
N.Y.). Ap value ofO.OS or less was considered to represent 
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Fig. 1. Liver regeneration after partial hepatectomy. Animals from placebo-treated control, cimetidine-treated 
(A), and ranitidine-treated (B) groups were killed by exsanguination at times noted. Data are presented as ratio 
of liver remnant weight to body weight at time killed and as mean ± SEM values with three to six animals 
per group. 
a significant difference. All results are presented as mean 
values ± SEM. 
RESULTS 
The increase in Ii ver remnant weight measured during 
the course of regeneration after two-thirds hepatic re-
section in control, cimetidine-treated, and ranitidine-
treated animals is presented in Fig. 1. No statistically 
significant difference between the three groups at 6 
hours or at any other time examined in the study was 
noted. Moreover, in Fig. 1, both A and B, should be 
noted that the rates at which the liver increased in weight 
after partial hepatectomy in cimetidine- and ranitidine-
treated animals, denoted by the slopes of the lines in 
the figure, did not differ from those of the vehicle-
treated controls, and no dose effect was seen for either 
agent. 
Preliminary experiments performed by us and other 
investigators demonstrated that the maximum induction 
of ornithine decarboxylase after partial hepatectomy oc-
curs 6 hours after surgery.9,13.15 Pretreatment with either 
drug at both the 1 x or 10 x dose did not alter the 
hepatic ornithine decarboxylase activity measured ini-
tially or that observed at peak levels seen after partial 
hepatectomy (Fig. 2). A comparable threefold increase 
in ornithine decarboxylase activity was observed in all 
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Fig. 2. Induction of ornithine decarboxylase activity by partial hepatectomy. A, Data from cirnetidine-treated 
animals. B, Data from ranitidine-treated animals. Data are presented as mean ± SEM values with three to six 
animals per group and are presented as counts per minute per milligram of protein per hour. 
treatment groups at 6 hours after partial hepatectomy 
when ornithine decarboxylase levels were expected to 
be increased maximally (Fig. 2). 
Thymidine kinase activity was induced also in all 
groups as a result of partial hepatectomy (Fig. 3). The 
activity of this enzyme reaches a maximum at 24 to 48 
hours after hepatectomy.lo No statistically significant 
difference in hepatic thymidine kinase activity either 
between the drug-treated groups and the vehicle-treated 
controls or between the various doses of either drug at 
any time point evaluated during the study was evident. 
Before hepatectomy, administration of the antian-
drogenic H2 receptor antagonist cimetidine caused a 
slight decrease in hepatic cytosolic androgen receptor 
content (Fig. 4). Conversely, ranitidine treatment re-
sulted in a significant increase in the hepatic cytosolic 
androgen receptor content. All differences between two 
groups of drug-treated animals and the vehicle-treated 
controls disappeared at 24 hours and remained no dif-
ferent through the next 24 hours. 
In contrast with the observations on the androgen 
receptor activity, pretreatment with the lowest dose of 
cimetidine caused a twofold increase in the hepatic cy-
tosolic content of estrogen receptor compared with that 
seen in the controls at time zero (Fig. 5, A), an effect 
not observed in the ranitidine-treated groups (Fig. 
5, B). Partial hepatectomy was followed by a sharp 
reduction in the cytosolic estrogen content in all animals 
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Fig. 3. Induction of thymidine kinase activity by partial hepatectomy. Data are presented as mean ± SEM 
values with three to six animals from the cimetidine (A) and ranitidine (B) groups. Ordinate is in disintegrations 
per minute per milligram protein X 1000. 
studied within 6 hours, reaching a nadir at 12 hours 
after partial hepatectomy and abolishing any difference 
between the treatment groupS. 
DISCUSSION 
This study was designed to examine the effect of 
hepatic sex honnone receptor modulation by two com-
monly used H2 antagonists, cimetidine and ranitidine, 
on the rate of hepatic regeneration that occurs after two-
thirds partial hepatectomy in the rat. It was hypothe-
sized that cimetidine, acting as an antiandrogen and 
augmenting hepatic demasculinization during regener-
ation after partial hepatectomy, might increase the rate 
of subsequent hepatic regeneration.4 Ranitidine was in-
cluded in the study as a control for the H2 antagonist 
effects of cimetidine, because this drug has no known 
anti androgenic effects. 
Significantly, neither drug was found to alter the rate 
of regeneration after partial hepatectomy. These results 
were somewhat unexpected for two reasons. First, as 
noted above, the regenerating liver has been reported 
to be more feminized than the nonregenerating liver.4 
Second, studies have been published claiming an in-
hibitory effect of both cimetidine and ranitidine on he-
patic regeneration in rats. 16,17 Conversely, data also have 
been published that suggest that cimetidine at supra-
pharmacologic doses enhances hepatic regeneration 
in vitrO. 18 
Our data demonstrate that the administration of ci-
metidine and ranitidine alters the cytosolic androgen 
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Fig. 4. Hepatic cytosolic androgen receptor content during hepatic regeneration. Bars represent mean ± SEM 
values with three to six animals per group. *p < 0.05 versus controls. 
receptor status of the liver before hepatic resection, 
although in different directions. Cimetidine treatment 
produced a reduction in androgen receptor activity, and 
ranitidine produced a small, and probably unimportant, 
increase in the androgen receptor activity of the liver. 
Cimetidine treatment also produced a significant in-
crease in the basal cytosolic estrogen receptor content 
of the rat liver when used at the dose used clinically 
but had either no effect or a paradoxic effect when used 
at the two larger doses. Ranitidine had no effect on the 
basal level of estrogen receptor activity within the liver 
before hepatectomy. After two-thirds hepatectomy, the 
androgen and estrogen receptor activities of the liver of 
the three groups of animals studied changed in a di-
rection characteristic of the regenerative process. Prior 
and continuing H2 receptor antagonist therapy had no 
effect on the changes produced by the regenerative pro-
cess per se, which have been described previously and 
which were replicated in the vehicle-treated control an-
imals.4 Because it is generally believed that sex hor-
mones, like other hormones, exert their effects through 
an interaction with specific receptors for the hormones 
in question, the changes observed in the concentrations 
of the two hepatic cytosolic sex hormone receptors stud-
ied before hepatectomy and induced by the two H2 
receptor antagonists used should represent alterations 
in the potential responsiveness of the liver to both an-
drogens and estrogens in response to prior drug treat-
ment. It should be noted, however, that the changes in 
sex hormone receptor activities induced as a result of 
H2 antagonist therapy were only modest. 
Despite these initial changes in the basal (time zero) 
receptor concentrations in the liver, the subsequent rate 
of hepatic regeneration and the changes in the cytosolic 
content of androgen and estrogen receptors after partial 
hepatectomy was not affected, as evidenced by parallel 
growth curves, regardless of the drug or dosage used 
in the experiments (Fig. 1) and data relative to the 
effects of the hepatic regenerative response on androgen 
and estrogen receptor activity within the liver (Figs. 4 
and 5). These data conflict somewhat with the conclu-
sions reached by earlier investigators, who have re-
ported an inhibition of regeneration in vivo with these 
two drugs, and others have reported an enhancement 
of the regenerative response, at least with cimetidine, 
when studied in vitro. 16- 18 The claim for an inhibition 
of the regenerative response was based primarily on the 
finding of a slight delay in the increase in the mitotic 
index and a lesser increase in the level of serum as-
partate aminotransferase activity observed after partial 
hepatectomy in the animals studied. It should be noted 
that the rate of liver growth in the drug-treated animals 
in these earlier studies was not significantly different 
from that of the controls at any time point examined. 
This latter observation is consistent with the data ob-
tained in the present study. 
The present study extends the previous studies in 
terms of the number of rats used, the number of drug 
dosages investigated and the variety of hepatic param-
eters examined. An important difference between the 
present study and the three previous studies16- 18 is that 
thymidine kinase activity was used instead of the mi-
totic index as a measure of DNA replication. It is well 
known that there is a good correlation between these 
two procedures in a variety of systemslO,19,20 and that 
the variance for the mitotic index is greater than that 
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Fig. 5. Hepatic cytosolic estrogen receptor content during hepatic regeneration. Hepatic cytosolic estrogen 
receptor concentrations in control, cimetidine-treated (A), and ranitidine-treated (B) rats were measured in same 
cytosolic extracts as androgen receptor concentrations. Ordinate is in disintegrations per minute per milligram 
protein X 1000. *p < 0.05 versus controls. 
of thymidine kinase activity. Nonetheless, it should be 
pointed out that the measurement of levels of thymidine 
kinase assumes similar precursor pools for the various 
groups of animals being studied, although the mitotic 
index relies less heavily on this assumption. 
In the present study, no difference between peak 
levels of hepatic thymidine kinase activity was observed 
between animal groups, regardless of the drug or dosage 
used. Moreover, the similar levels of hepatic ornithine 
decarboxylase activity, an indicator of the increase in 
polyamine synthesis thought to signal hepatic regen-
eration, between the various groups studied further sup-
ports a lack of an effect of either H2 antagonist on the 
regenerative process of the liver. 13 
An unexpected observation noted during the course 
of this study was that although pretreatment with both 
drugs induced alterations in the prehepatectomy con-
centration of hepatic cytosolic androgen and estrogen 
receptors, these drug effects on the cytosolic content 
of steroid hormone receptors disappeared within as little 
as 6 hours after partial hepatectomy. Presumably, some 
unknown overriding mechanisms are initiated or take 
over after partial hepatectomy, such that hepatic regen-
eration occurs regardless of the basal sex hormone re-
ceptor status of the liver, and the sex hormone receptor 
activities change as a consequence of regeneration 
rather than in response to earlier and continued H2 re-
ceptor antagonist treatment. 
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On the basis of the present data, it is not possible to 
determine whether this overriding mechanism origi-
nates within the liver itself or whether it is extrahepatic 
in origin. Some of the effects originally attributed to 
the interaction of sex hormones with their receptors 
within the liver have been shown to be mediated by the 
pituitary.3.21.23 An alternative liver-based mechanism 
that could be active in these studies is the production 
of a putative growth-stimulating factor thought to be 
released into the serum by injured or regenerating liver 
tissue.24-26 No investigations have yet been published 
on the effect of such a material or materials on the 
activity of hepatic sex hormone receptors present within 
liver cells. 
In summary, the data presented do not support the 
earlier published conclusion that either cimetidine or 
ranitidine inhibits the rate of hepatic regeneration ob-
served after a two-thirds hepatectomy in the rat. Neither 
agent had a lasting detectable effect on a variety of 
parameters associated with hepatic regeneration, in-
cluding thymidine kinase activity, ornithine decarbox-
ylase activity, and the level of two major sex hormone 
receptor levels within the liver after partial hepa-
tectomy. 
We thank Joan Willett and Judy Wargo for technical assistance. 
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